143 related articles for article (PubMed ID: 21047685)
1. A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats.
Boules M; Oliveros A; Liang Y; Williams K; Shaw A; Robinson J; Fredrickson P; Richelson E
Neuropeptides; 2011 Feb; 45(1):9-16. PubMed ID: 21047685
[TBL] [Abstract][Full Text] [Related]
2. The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat.
Boules M; Iversen I; Oliveros A; Shaw A; Williams K; Robinson J; Fredrickson P; Richelson E
Brain Res; 2007 Jan; 1127(1):90-8. PubMed ID: 17113052
[TBL] [Abstract][Full Text] [Related]
3. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
[TBL] [Abstract][Full Text] [Related]
4. Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats.
Fredrickson P; Boules M; Yerbury S; Richelson E
Eur J Pharmacol; 2003 Jan; 458(1-2):111-8. PubMed ID: 12498914
[TBL] [Abstract][Full Text] [Related]
5. Effects of 5 daily injections of the neurotensin-mimetic NT69L on the expression of neurotensin receptors in rat brain.
Wang R; Boules M; Gollatz E; Williams K; Tiner W; Richelson E
Brain Res Mol Brain Res; 2005 Jul; 138(1):24-34. PubMed ID: 15878217
[TBL] [Abstract][Full Text] [Related]
6. Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization.
Fredrickson P; Boules M; Yerbury S; Richelson E
Brain Res; 2003 Jul; 979(1-2):245-8. PubMed ID: 12850594
[TBL] [Abstract][Full Text] [Related]
7. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux.
Prus AJ; Huang M; Li Z; Dai J; Meltzer HY
Brain Res; 2007 Dec; 1184():354-64. PubMed ID: 17988654
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys.
Fantegrossi WE; Ko MC; Woods JH; Richelson E
Pharmacol Biochem Behav; 2005 Feb; 80(2):341-9. PubMed ID: 15680187
[TBL] [Abstract][Full Text] [Related]
9. A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents.
Boules M; Cusack B; Zhao L; Fauq A; McCormick DJ; Richelson E
Brain Res; 2000 May; 865(1):35-44. PubMed ID: 10814731
[TBL] [Abstract][Full Text] [Related]
10. The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.
Li Z; Boules M; Williams K; Peris J; Richelson E
Brain Res; 2010 Jan; 1311():28-36. PubMed ID: 19948149
[TBL] [Abstract][Full Text] [Related]
11. Effects of repeated injections of the neurotensin analog NT69L on dopamine release and uptake in rat striatum in vitro.
Wang R; Boules M; Tiner W; Richelson E
Brain Res; 2004 Oct; 1025(1-2):21-8. PubMed ID: 15464740
[TBL] [Abstract][Full Text] [Related]
12. IV nicotine self-administration in rats using the consummatory operant licking response.
Levin ED; Hampton D; Rose JE
Physiol Behav; 2010 Dec; 101(5):755-8. PubMed ID: 20804779
[TBL] [Abstract][Full Text] [Related]
13. Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier.
Boules M; McMahon B; Wang R; Warrington L; Stewart J; Yerbury S; Fauq A; McCormick D; Richelson E
Brain Res; 2003 Oct; 987(1):39-48. PubMed ID: 14499944
[TBL] [Abstract][Full Text] [Related]
14. A neurotensin analog blocks cocaine-conditioned place preference and reinstatement.
Boules M; Netz R; Fredrickson PA; Richelson E
Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):236-9. PubMed ID: 26901162
[TBL] [Abstract][Full Text] [Related]
15. The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.
Shilling PD; Richelson E; Feifel D
Behav Brain Res; 2003 Jul; 143(1):7-14. PubMed ID: 12842291
[TBL] [Abstract][Full Text] [Related]
16. NT69L blocks ethanol-induced increase of dopamine and glutamate levels in striatum of mouse.
Li Z; Boules M; Richelson E
Neurosci Lett; 2011 Jan; 487(3):322-4. PubMed ID: 20974215
[TBL] [Abstract][Full Text] [Related]
17. NT69L, a novel analgesic, shows synergy with morphine.
Boules M; Shaw A; Liang Y; Barbut D; Richelson E
Brain Res; 2009 Oct; 1294():22-8. PubMed ID: 19651107
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
[TBL] [Abstract][Full Text] [Related]
19. The GABAB agonist baclofen modifies cocaine self-administration in rats.
Shoaib M; Swanner LS; Beyer CE; Goldberg SR; Schindler CW
Behav Pharmacol; 1998 May; 9(3):195-206. PubMed ID: 9832934
[TBL] [Abstract][Full Text] [Related]
20. Prenatal nicotine exposure changes natural and drug-induced reinforcement in adolescent male rats.
Franke RM; Park M; Belluzzi JD; Leslie FM
Eur J Neurosci; 2008 Jun; 27(11):2952-61. PubMed ID: 18588535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
